Trial Profile
A Phase II Study of Temozolomide, Thalidomide, and Lomustine (TTL) in Patients With Metastatic Melanoma in the Brain
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 10 Jun 2013
Price :
$35
*
At a glance
- Drugs Lomustine (Primary) ; Temozolomide; Thalidomide
- Indications Brain metastases; Malignant melanoma
- Focus Therapeutic Use
- 10 Jun 2013 New trial record